HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $539,624 | -79.4% | 16,467 | -77.9% | 0.00% | -100.0% |
| Q2 2023 | $2,620,776 | +66.7% | 74,475 | +54.6% | 0.00% | 0.0% |
| Q1 2023 | $1,572,490 | -76.9% | 48,162 | -61.0% | 0.00% | -75.0% |
| Q4 2022 | $6,800,883 | +252.6% | 123,428 | +183.3% | 0.00% | +300.0% |
| Q3 2022 | $1,929,000 | +199.1% | 43,566 | +229.7% | 0.00% | – |
| Q2 2022 | $645,000 | 0.0% | 13,214 | -0.4% | 0.00% | – |
| Q1 2022 | $645,000 | +4.4% | 13,268 | -8.6% | 0.00% | – |
| Q4 2021 | $618,000 | -82.4% | 14,511 | -84.1% | 0.00% | -100.0% |
| Q3 2021 | $3,502,000 | +49.2% | 91,376 | +9.9% | 0.00% | +100.0% |
| Q2 2021 | $2,347,000 | +1691.6% | 83,121 | +1989.0% | 0.00% | – |
| Q1 2021 | $131,000 | -17.1% | 3,979 | -8.7% | 0.00% | – |
| Q4 2020 | $158,000 | – | 4,357 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $367,614,941 | 98.94% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,081,152 | 9.78% |
| venBio Partners LLC | 1,035,396 | $33,929,927 | 9.62% |
| Vivo Capital, LLC | 2,606,247 | $85,406,714 | 9.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 314,500 | $10,306,165 | 3.47% |
| AlphaCentric Advisors LLC | 122,000 | $3,997,940 | 2.27% |
| ASHFORD CAPITAL MANAGEMENT INC | 434,148 | $14,227,030 | 2.09% |
| Altium Capital Management LP | 117,000 | $3,834,090 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 595,490 | $19,514,207 | 1.90% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $8,887,224 | 1.25% |